At Bristol-Myers Squibb, our mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. StudyConnect is the starting point for patients and caregivers, considering taking part in a clinical trial – a process to help make sure new medicines are effective and safe.
Celgene currently sponsors more than 100 clinical trials examining at least 25 unique compounds. Approximately 28,000 patients are actively enrolled in Celgene-sponsored clinical trials, for more than 50 different indications. The corresponding treatments are aimed at addressing the unmet needs of 25 million people worldwide in more than 30 disease areas.
Merck cares deeply about helping the world be well. We strive to improve health for others in the future by developing new drugs and vaccines that treat and prevent disease. Clinical trials are an essential part of this process. We are thankful for the thousands of volunteers — patients and healthy persons — who participate… read more //